April 1st, 2015
An alliance for better therapies
Through academic-industry partnership, a familiar toxin may become a lifesaver for patients with neuromuscular disorders
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
April 1st, 2015
Ipsen expands ties to Harvard University with signing of a new Research Alliance Agreement
Paris (France), 1 April 2015 - Ipsen (Euronext: IPN, ADR: IPSEY) announced today that it has signed a multi-year research alliance agreement with Harvard University in Cambridge, Mass.
March 25th, 2015
March 2015 Patents: Compositions and methods for labeling and imaging phospholipids, all-optical logic gates, and more
Professors Eric Mazur, Jene Golovchenko, George Whitesides, and David Weitz are among the faculty members to be issued US patents this March.
March 4th, 2015
Harvard startup launches with $22M Series A financing to develop novel macrolide antibiotics
NEWTON, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, a new company with groundbreaking technology to develop novel antibiotics, completed a Series A financing of $22 million led by Novartis Venture Fund, Gurnet Point Capital, Roche Ventures, and SROne. The financing follows a worldwide license agreement between Harvard's Office of Technology Development and the company, providing exclusive rights to the technology.
October 29th, 2014
October 2014 patents: microfluidic systems, new screening assays, and more
Professors David Weitz and J. Christopher Love are among the faculty members to be issued US patents this October.